Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Find therapies in clinical trials near you – page 22

recruiting
3 987
countries
28
conditions
2 109

334 trials match your criteria

Neuromyelitis optica spectrum disorder

Not recruiting

Study on the Effectiveness and Safety of Ravulizumab for Children and Adolescents with Neuromyelitis Optica Spectrum Disorder (NMOSD)

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Ravulizumab

Multiple sclerosis

Not recruiting

Study on the Safety and Effectiveness of Fingolimod and Interferon Beta-1a in Children with Multiple Sclerosis

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Fingolimod

Foetal growth restriction

Not recruiting

Study Comparing Cook's Balloon and Dinoprostone for Inducing Labor in Pregnant Women with Fetal Growth Restriction at Term

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Dinoprostone

Metabolic disorder

Not recruiting

Study on the Effects of GLM101 for Patients with PMM2-CDG

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Alfa-D-Mannopyranosyl Phosphate Dipotassium

Infection in an immunocompromised host

Not recruiting

Study on Maribavir for Treating Cytomegalovirus in Children and Adolescents Post-Transplant

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Maribavir

Influenza

Not recruiting

Study of intravenous zanamivir safety and effectiveness in infants under 6 months of age with complicated influenza infection

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Zanamivir

Partial seizures

Not recruiting

Study on the Safety and Effectiveness of Cenobamate for Children with Focal Seizures

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Cenobamate

Hypertrophic cardiomyopathy

Not recruiting

Study of Mavacamten for Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Investigational
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Mavacamten

Neoplasm malignant+1

Not recruiting

Study of Niraparib and Dostarlimab for Children with Recurrent or Hard-to-Treat Solid Tumors

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Dostarlimab

Gaucher's disease type III+1

Not recruiting

Study of Eliglustat alone or with imiglucerase in children and adolescents aged 2-17 years with Gaucher disease type 1 and type 3

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Eliglustat Tartrate

Congenital cystic kidney disease

Not recruiting

Study on the Safety and Effects of Tolvaptan for Infants and Young Children with Autosomal Recessive Polycystic Kidney Disease

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Tolvaptan

Osteochondrodysplasia

Not recruiting

Study on the Long-Term Safety and Effectiveness of Vosoritide for Children with Achondroplasia

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Vosoritide

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.